Effect of Topical Timolol on Post Acne Erythema

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N22

Enrollment

Registered

2021-03-23

Start date

2021-04-04

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne. Acne

Interventions

Intervention 1: Intervention group: Patients will be included in this group after random allocation. Twenty patients at Sina Hospital with acne and erythema will use thymoline ointment three times a d

Eligibility

Sex/Gender

All

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Active erythema Having acne Satisfaction to participate in the research project

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding Having asthma History of high blood pressure

Design outcomes

Primary

Measure	Time frame
Acne number. Timepoint: Once a day for thirty days. Method of measurement: Observation and examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026